US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Chemomab Therapeutics Ltd.

2.74

+0.02000.74%

Volume:38.22K

Turnover:106.73K

Market Cap:20.08M

PE:-2.72

High:2.89

Open:2.81

Low:2.71

Close:2.72

52wk High:3.58

52wk Low:1.35

Shares:7.33M

Float Shares:6.14M

Volume Ratio:0.52

T/O Rate:0.62%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.0070

EPS(LYR):-1.4103

ROE:-82.17%

ROA:-46.27%

PB:2.31

PE(LYR):-1.94

Loading ...

Overview Company News Filings

Chemomab Therapeutics Ltd reports results for the quarter ended March 31 - Earnings Summary

Chemomab Q1 FY26 net loss narrows to $1.8 million

Press Release: Chemomab Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update

Chemomab Therapeutics Ltd expected to post a loss of 15 cents a share - Earnings Preview

Chemomab Therapeutics holds annual shareholders meeting, re-elects directors

Chemomab Therapeutics director Neil Cohen files initial beneficial ownership statement

Chemomab Therapeutics files Form 3 as director Nissim Darvish reports holdings

Chemomab files Form 3 for CFO Fatal Sigal’s initial beneficial ownership stake

Chemomab files Form 3 for Chief Development Officer John Lawler

Chemomab files initial beneficial ownership statement for director Claude Nicaise

Chemomab files Form 3 for director Jill Quigley’s beneficial ownership statement

Maxim Group Remains a Buy on Chemomab Therapeutics (CMMB)

Chemomab FY 2025 net loss fell 35.5% to USD 9 million

Chemomab Therapeutics: Evaluating Additional Therapeutic Indications Where Nebokitug Has Generated Robust Preclinical Efficacy Signals

THOMSON REUTERS

Chemomab Therapeutics Q4 Operating Expenses USD 1.974 Million

THOMSON REUTERS

Press Release: Chemomab Therapeutics Announces Year End and Fourth Quarter 2025 Financial Results and Provides a Corporate Update

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/CMMB/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CMMB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CMMB\",,,,,undefined,":{"symbol":"CMMB","market":"US","secType":"STK","nameCN":"Chemomab Therapeutics Ltd.","latestPrice":2.74,"timestamp":1788276702201,"preClose":2.72,"halted":0,"volume":38222,"delay":0,"changeRate":0.007352941176470594,"floatShares":6144100,"shares":7327700,"eps":-1.006975,"marketStatus":"Trading","change":0.02,"latestTime":"09-01 11:40:05 EDT","open":2.805,"high":2.89,"low":2.71,"amount":106734.5986464,"amplitude":0.066176,"askPrice":2.76,"askSize":44,"bidPrice":2.69,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.006975,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788292800000},"marketStatusCode":2,"adr":0,"adrRate":80,"listingDate":1549947600000,"exchange":"NASDAQ","adjPreClose":2.72,"preHourTrading":{"tag":"盘前","latestPrice":2.7828,"preClose":2.72,"latestTime":"09:15 EDT","volume":618,"amount":1721.019378,"timestamp":1788268515384,"change":0.0628,"changeRate":0.023088,"amplitude":0.176103},"postHourTrading":{"tag":"盘后","latestPrice":2.71,"preClose":2.72,"latestTime":"19:34 EDT","volume":651,"amount":1765.7167,"timestamp":1788219292913,"change":-0.01,"changeRate":-0.003676,"amplitude":0.003676},"volumeRatio":0.522185},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CMMB\",,,,,undefined,":{"symbol":"CMMB","floatShares":6144100,"roa":"-46.27%","roe":"-82.17%","lyrEps":-1.41035,"volumeRatio":0.522185,"shares":7327700,"dividePrice":0,"high":2.89,"amplitude":0.066176,"preClose":2.72,"low":2.71,"week52Low":1.35,"pbRate":"2.31","week52High":3.58,"institutionHeld":0,"latestPrice":2.74,"committee":0.388889,"eps":-1.006975,"divideRate":0,"volume":38222,"delay":0,"ttmEps":-1.006975,"open":2.805,"prevYearClose":1.65,"prevWeekClose":2.71,"prevMonthClose":2.72,"prevQuarterClose":1.62,"fiveDayClose":2.3,"twentyDayClose":1.68,"sixtyDayClose":1.77},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CMMB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-19","symbol":"CMMB","fiscalQuarterEnding":"2026/06","expectedEps":0,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1787112000000,"reportTimeType":"pre","actualEps":-0.27},{"market":"US","date":"2026-05-14","symbol":"CMMB","fiscalQuarterEnding":"2026/03","expectedEps":0,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778731200000,"reportTimeType":"pre","actualEps":-0.22},{"market":"US","date":"2026-03-19","symbol":"CMMB","fiscalQuarterEnding":"2025/12","expectedEps":-0.2,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1773892800000,"reportTimeType":"pre","actualEps":-0.24},{"date":"2025-11-20","symbol":"CMMB","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1763629200000,"name":null,"time":"Pre-MKt","dateTimestamp":1763614800000,"actualEps":null},{"market":"US","date":"2025-08-26","symbol":"CMMB","defaultRemindTime":1756215000000,"type":"split","dateTimestamp":1756180800000,"forFactor":4,"toFactor":1,"ratio":4}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CMMB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CMMB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":2,"updateTime":1755835200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CMMB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CMMB","date":"2026-08-31","current":-2.721021,"percent":0.178015,"low":-22.411159,"twenty":-2.393239,"median":-1.379007,"eighty":-0.610838,"high":-0.182948,"avg":-2.418293,"sd":3.585577,"marketCap":19635594},"quantilePoints":[{"date":"2021-09-03","current":-21.830019,"twenty":-51.63647,"median":-34.004385,"eighty":-29.866616,"marketCap":166977813},{"date":"2021-09-10","current":-20.921056,"twenty":-51.104358,"median":-33.811785,"eighty":-29.763523,"marketCap":160025154},{"date":"2021-09-17","current":-19.356447,"twenty":-50.507592,"median":-33.72871,"eighty":-23.209855,"marketCap":148057460},{"date":"2021-09-24","current":-17.940848,"twenty":-50.0977,"median":-33.451791,"eighty":-22.083336,"marketCap":137229548},{"date":"2021-10-01","current":-16.09312,"twenty":-49.378648,"median":-32.787186,"eighty":-21.645246,"marketCap":123096272},{"date":"2021-10-08","current":-13.79836,"twenty":-48.842921,"median":-32.38764,"eighty":-20.041894,"marketCap":105543655},{"date":"2021-10-15","current":-13.545042,"twenty":-47.591697,"median":-32.177965,"eighty":-19.326645,"marketCap":103606029},{"date":"2021-10-22","current":-15.184156,"twenty":-44.493144,"median":-31.510627,"eighty":-18.820009,"marketCap":116143612},{"date":"2021-10-29","current":-14.971519,"twenty":-42.758824,"median":-31.144134,"eighty":-18.268671,"marketCap":114517146},{"date":"2021-11-05","current":-14.543412,"twenty":-42.16739,"median":-30.783862,"eighty":-18.057076,"marketCap":111242557},{"date":"2021-11-12","current":-11.785515,"twenty":-41.656517,"median":-30.627219,"eighty":-16.67426,"marketCap":110701340},{"date":"2021-11-19","current":-11.190777,"twenty":-41.444646,"median":-30.586219,"eighty":-15.443434,"marketCap":105114970},{"date":"2021-11-26","current":-10.765965,"twenty":-41.153826,"median":-30.524667,"eighty":-15.011304,"marketCap":101124705},{"date":"2021-12-03","current":-9.273052,"twenty":-40.769832,"median":-30.263126,"eighty":-14.901037,"marketCap":87101775},{"date":"2021-12-10","current":-9.697864,"twenty":-40.614757,"median":-30.137996,"eighty":-14.716264,"marketCap":91092040},{"date":"2021-12-17","current":-8.119989,"twenty":-40.24184,"median":-29.851847,"eighty":-14.22751,"marketCap":76271057},{"date":"2021-12-23","current":-9.151677,"twenty":-39.898461,"median":-29.778485,"eighty":-14.030817,"marketCap":85961700},{"date":"2021-12-31","current":-8.374877,"twenty":-39.710156,"median":-29.015625,"eighty":-13.774518,"marketCap":78665216},{"date":"2022-01-07","current":-8.171232,"twenty":-39.252317,"median":-22.70918,"eighty":-13.5212,"marketCap":76752379},{"date":"2022-01-14","current":-7.989109,"twenty":-38.266486,"median":-22.209995,"eighty":-11.707835,"marketCap":75041702},{"date":"2022-01-21","current":-6.54427,"twenty":-38.104027,"median":-21.98648,"eighty":-11.020852,"marketCap":61470330},{"date":"2022-01-28","current":-5.73079,"twenty":-37.180964,"median":-21.830019,"eighty":-10.620315,"marketCap":53829306},{"date":"2022-02-04","current":-5.524384,"twenty":-35.899319,"median":-20.950858,"eighty":-9.843514,"marketCap":51890538},{"date":"2022-02-11","current":-5.281554,"twenty":-35.881369,"median":-19.997191,"eighty":-9.564352,"marketCap":49609635},{"date":"2022-02-18","current":-4.68662,"twenty":-35.683959,"median":-19.468204,"eighty":-9.151677,"marketCap":44021424},{"date":"2022-02-25","current":-4.905167,"twenty":-35.655196,"median":-19.095678,"eighty":-8.816682,"marketCap":46074236},{"date":"2022-03-04","current":-4.832318,"twenty":-35.500855,"median":-18.849811,"eighty":-8.469356,"marketCap":45389965},{"date":"2022-03-11","current":-3.838673,"twenty":-35.404992,"median":-18.440033,"eighty":-8.377085,"marketCap":47898958},{"date":"2022-03-18","current":-4.094584,"twenty":-35.168688,"median":-18.223968,"eighty":-8.190926,"marketCap":51092222},{"date":"2022-03-25","current":-4.551569,"twenty":-35.067209,"median":-18.134562,"eighty":-7.9813,"marketCap":56794479},{"date":"2022-04-01","current":-4.414474,"twenty":-34.998397,"median":-17.806739,"eighty":-7.073639,"marketCap":55083807},{"date":"2022-04-08","current":-3.756416,"twenty":-34.806847,"median":-16.659359,"eighty":-6.204308,"marketCap":46872556},{"date":"2022-04-14","current":-3.482225,"twenty":-34.72931,"median":-16.301735,"eighty":-5.920197,"marketCap":43451202},{"date":"2022-04-22","current":-3.098358,"twenty":-34.657798,"median":-15.184156,"eighty":-5.670082,"marketCap":38661305},{"date":"2022-04-29","current":-2.879005,"twenty":-34.581814,"median":-15.020245,"eighty":-5.478246,"marketCap":35924222},{"date":"2022-05-06","current":-2.769328,"twenty":-34.456166,"median":-14.94574,"eighty":-5.310694,"marketCap":34555680},{"date":"2022-05-13","current":-2.003871,"twenty":-34.163888,"median":-14.878685,"eighty":-5.05815,"marketCap":31817456},{"date":"2022-05-20","current":-2.169142,"twenty":-34.002839,"median":-14.752026,"eighty":-4.844835,"marketCap":34441635},{"date":"2022-05-27","current":-2.176324,"twenty":-33.902348,"median":-14.580665,"eighty":-4.626514,"marketCap":34555680},{"date":"2022-06-03","current":-2.434898,"twenty":-33.817324,"median":-14.237941,"eighty":-4.492371,"marketCap":38661305},{"date":"2022-06-10","current":-2.715019,"twenty":-33.769325,"median":-14.066579,"eighty":-4.410209,"marketCap":43109066},{"date":"2022-06-17","current":-2.38462,"twenty":-33.739787,"median":-13.880316,"eighty":-4.319081,"marketCap":37862989},{"date":"2022-06-24","current":-2.944862,"twenty":-33.713941,"median":-13.783459,"eighty":-4.118347,"marketCap":46758511},{"date":"2022-07-01","current":-2.38462,"twenty":-33.643788,"median":-13.559943,"eighty":-3.866092,"marketCap":37862989},{"date":"2022-07-08","current":-2.485176,"twenty":-33.599481,"median":-13.51524,"eighty":-3.756416,"marketCap":39459621},{"date":"2022-07-15","current":-2.269698,"twenty":-33.304101,"median":-11.785515,"eighty":-3.62846,"marketCap":36038267},{"date":"2022-07-22","current":-2.327159,"twenty":-33.008721,"median":-11.22719,"eighty":-3.463945,"marketCap":36950628},{"date":"2022-07-29","current":-2.19069,"twenty":-32.787186,"median":-10.966233,"eighty":-3.116637,"marketCap":34783770},{"date":"2022-08-05","current":-2.513906,"twenty":-32.731802,"median":-10.765965,"eighty":-2.94127,"marketCap":39915802},{"date":"2022-08-12","current":-2.369501,"twenty":-32.452984,"median":-10.371496,"eighty":-2.888144,"marketCap":45726624},{"date":"2022-08-19","current":-1.978533,"twenty":-32.322296,"median":-9.843514,"eighty":-2.860251,"marketCap":38181731},{"date":"2022-08-26","current":-1.990381,"twenty":-32.177965,"median":-9.637176,"eighty":-2.779662,"marketCap":38410364},{"date":"2022-09-02","current":-2.008152,"twenty":-32.177965,"median":-9.479389,"eighty":-2.679106,"marketCap":38753313},{"date":"2022-09-09","current":-2.049618,"twenty":-31.882584,"median":-9.273052,"eighty":-2.612619,"marketCap":39553529},{"date":"2022-09-16","current":-1.777126,"twenty":-31.778465,"median":-8.927133,"eighty":-2.564697,"marketCap":34294968},{"date":"2022-09-23","current":-1.463167,"twenty":-31.354465,"median":-8.739002,"eighty":-2.498104,"marketCap":28236190},{"date":"2022-09-30","current":-1.475014,"twenty":-31.207278,"median":-8.515854,"eighty":-2.472247,"marketCap":28464823},{"date":"2022-10-07","current":-1.380234,"twenty":-31.154609,"median":-8.414062,"eighty":-2.410477,"marketCap":26635758},{"date":"2022-10-14","current":-1.18475,"twenty":-31.070289,"median":-8.376257,"eighty":-2.383874,"marketCap":22863312},{"date":"2022-10-21","current":-1.18475,"twenty":-30.888924,"median":-8.219798,"eighty":-2.366779,"marketCap":22863312},{"date":"2022-10-28","current":-1.19956,"twenty":-30.74526,"median":-8.177302,"eighty":-2.332598,"marketCap":23149103},{"date":"2022-11-04","current":-1.18475,"twenty":-30.704756,"median":-7.989109,"eighty":-2.268262,"marketCap":22863312},{"date":"2022-11-11","current":-0.982108,"twenty":-30.641988,"median":-7.738926,"eighty":-2.226603,"marketCap":23973258},{"date":"2022-11-18","current":-0.98683,"twenty":-30.623139,"median":-6.568553,"eighty":-2.207222,"marketCap":24088514},{"date":"2022-11-25","current":-0.973845,"twenty":-30.622119,"median":-6.337865,"eighty":-2.187817,"marketCap":23771560},{"date":"2022-12-02","current":-1.038768,"twenty":-30.57904,"median":-6.05861,"eighty":-2.171771,"marketCap":25356331},{"date":"2022-12-09","current":-1.133202,"twenty":-30.541076,"median":-5.876487,"eighty":-2.146158,"marketCap":27661452},{"date":"2022-12-16","current":-0.963221,"twenty":-30.522618,"median":-5.700436,"eighty":-2.044879,"marketCap":23512234},{"date":"2022-12-23","current":-1.114315,"twenty":-30.382719,"median":-5.597233,"eighty":-2.00644,"marketCap":27200427},{"date":"2022-12-30","current":-1.510936,"twenty":-30.282201,"median":-5.512242,"eighty":-1.983272,"marketCap":36881936},{"date":"2023-01-06","current":-1.067098,"twenty":-30.2621,"median":-5.41511,"eighty":-1.948914,"marketCap":26047867},{"date":"2023-01-13","current":-1.067098,"twenty":-30.239533,"median":-5.305837,"eighty":-1.937067,"marketCap":26047867},{"date":"2023-01-20","current":-1.067098,"twenty":-30.165688,"median":-5.269412,"eighty":-1.931143,"marketCap":26047867},{"date":"2023-01-27","current":-0.982108,"twenty":-30.110304,"median":-5.050865,"eighty":-1.853108,"marketCap":23973258},{"date":"2023-02-03","current":-1.048212,"twenty":-29.870308,"median":-4.879173,"eighty":-1.605337,"marketCap":25586843},{"date":"2023-02-10","current":-0.977386,"twenty":-29.851847,"median":-4.747328,"eighty":-1.480938,"marketCap":23858002},{"date":"2023-02-17","current":-0.925448,"twenty":-29.850284,"median":-4.624687,"eighty":-1.427624,"marketCap":22590185},{"date":"2023-02-24","current":-0.691463,"twenty":-29.792845,"median":-4.539264,"eighty":-1.380234,"marketCap":19116174},{"date":"2023-03-03","current":-0.671478,"twenty":-29.74856,"median":-4.460173,"eighty":-1.350616,"marketCap":18563684},{"date":"2023-03-10","current":-0.59154,"twenty":-29.297133,"median":-4.41092,"eighty":-1.241662,"marketCap":16353721},{"date":"2023-03-17","current":-0.587543,"twenty":-28.913312,"median":-4.377915,"eighty":-1.213184,"marketCap":16243223},{"date":"2023-03-24","current":-0.6435,"twenty":-24.603931,"median":-4.285951,"eighty":-1.204298,"marketCap":17790197},{"date":"2023-03-31","current":-0.635506,"twenty":-22.876072,"median":-4.094584,"eighty":-1.196586,"marketCap":17569201},{"date":"2023-04-06","current":-0.571556,"twenty":-22.530367,"median":-3.902651,"eighty":-1.18475,"marketCap":15801231},{"date":"2023-04-14","current":-0.631509,"twenty":-22.348575,"median":-3.847812,"eighty":-1.176457,"marketCap":17458702},{"date":"2023-04-21","current":-0.631509,"twenty":-22.190624,"median":-3.756416,"eighty":-1.136035,"marketCap":17458702},{"date":"2023-04-28","current":-0.611525,"twenty":-22.068435,"median":-3.669588,"eighty":-1.107705,"marketCap":16906212},{"date":"2023-05-05","current":-0.575553,"twenty":-21.976049,"median":-3.591901,"eighty":-1.091651,"marketCap":15911729},{"date":"2023-05-12","current":-0.645498,"twenty":-21.904524,"median":-3.482225,"eighty":-1.080319,"marketCap":17845446},{"date":"2023-05-19","current":-0.649677,"twenty":-21.8479,"median":-3.422817,"eighty":-1.070403,"marketCap":20331654},{"date":"2023-05-26","current":-0.57906,"twenty":-21.645246,"median":-3.116637,"eighty":-1.067098,"marketCap":18121691},{"date":"2023-06-02","current":-0.564937,"twenty":-21.290602,"median":-2.980774,"eighty":-1.057655,"marketCap":17679699},{"date":"2023-06-09","current":-0.6179,"twenty":-20.968739,"median":-2.932987,"eighty":-1.044434,"marketCap":19337171},{"date":"2023-06-15","current":-0.600245,"twenty":-20.921056,"median":-2.919439,"eighty":-1.034046,"marketCap":18784680},{"date":"2023-06-23","current":-0.473135,"twenty":-20.241568,"median":-2.883574,"eighty":-1.018937,"marketCap":14806748},{"date":"2023-06-30","current":-0.430764,"twenty":-20.026993,"median":-2.869865,"eighty":-0.989663,"marketCap":13480770},{"date":"2023-07-07","current":-0.459011,"twenty":-19.913745,"median":-2.851348,"eighty":-0.982108,"marketCap":14364755},{"date":"2023-07-14","current":-0.49432,"twenty":-19.705131,"median":-2.822757,"eighty":-0.977386,"marketCap":15469736},{"date":"2023-07-21","current":-0.480196,"twenty":-19.490556,"median":-2.763721,"eighty":-0.967943,"marketCap":15027744},{"date":"2023-07-28","current":-0.45548,"twenty":-19.341546,"median":-2.697062,"eighty":-0.963221,"marketCap":14254257},{"date":"2023-08-04","current":-0.441357,"twenty":-19.207436,"median":-2.650375,"eighty":-0.95,"marketCap":13812265},{"date":"2023-08-11","current":-0.416641,"twenty":-18.903456,"median":-2.603688,"eighty":-0.926392,"marketCap":13038778},{"date":"2023-08-18","current":-0.350788,"twenty":-18.873653,"median":-2.577395,"eighty":-0.820525,"marketCap":11602302},{"date":"2023-08-25","current":-0.371693,"twenty":-18.83491,"median":-2.513906,"eighty":-0.685068,"marketCap":12293748},{"date":"2023-09-01","current":-0.396711,"twenty":-18.775306,"median":-2.49595,"eighty":-0.671478,"marketCap":13121212},{"date":"2023-09-08","current":-0.375267,"twenty":-18.596494,"median":-2.485176,"eighty":-0.653892,"marketCap":12411957},{"date":"2023-09-15","current":-0.382415,"twenty":-18.432582,"median":-2.463628,"eighty":-0.647497,"marketCap":12648375},{"date":"2023-09-22","current":-0.375267,"twenty":-18.361057,"median":-2.434898,"eighty":-0.647497,"marketCap":12411957},{"date":"2023-09-27","current":-0.332236,"twenty":-18.319334,"median":-2.424124,"eighty":-0.647097,"marketCap":10988719},{"date":"2023-10-06","current":-0.297676,"twenty":-18.238869,"median":-2.391802,"eighty":-0.639503,"marketCap":9845637},{"date":"2023-10-13","current":-0.31987,"twenty":-18.197146,"median":-2.38462,"eighty":-0.635506,"marketCap":10579716},{"date":"2023-10-20","current":-0.300214,"twenty":-18.152443,"median":-2.373845,"eighty":-0.631509,"marketCap":9929566},{"date":"2023-10-27","current":-0.293209,"twenty":-18.134562,"median":-2.369878,"eighty":-0.631509,"marketCap":9697876},{"date":"2023-11-03","current":-0.271479,"twenty":-18.134562,"median":-2.348707,"eighty":-0.623515,"marketCap":8979164},{"date":"2023-11-10","current":-0.214438,"twenty":-17.940848,"median":-2.330558,"eighty":-0.619518,"marketCap":7092547},{"date":"2023-11-17","current":-0.268324,"twenty":-17.806739,"median":-2.284063,"eighty":-0.615522,"marketCap":7801801},{"date":"2023-11-24","current":-0.225636,"twenty":-17.38951,"median":-2.262516,"eighty":-0.611525,"marketCap":6560606},{"date":"2023-12-01","current":-0.219132,"twenty":-16.844132,"median":-2.23375,"eighty":-0.607528,"marketCap":6371471},{"date":"2023-12-08","current":-0.195186,"twenty":-16.614656,"median":-2.212237,"eighty":-0.602874,"marketCap":5675219},{"date":"2023-12-15","current":-0.20287,"twenty":-16.52525,"median":-2.203715,"eighty":-0.59911,"marketCap":5898635},{"date":"2023-12-22","current":-0.199211,"twenty":-16.176566,"median":-2.19069,"eighty":-0.595537,"marketCap":5792246},{"date":"2023-12-29","current":-0.215473,"twenty":-15.902386,"median":-2.179915,"eighty":-0.59154,"marketCap":6265083},{"date":"2024-01-05","current":-0.215473,"twenty":-15.616286,"median":-2.176324,"eighty":-0.583546,"marketCap":6265083},{"date":"2024-01-12","current":-0.227588,"twenty":-15.184156,"median":-2.169142,"eighty":-0.575553,"marketCap":6617346},{"date":"2024-01-19","current":-0.217912,"twenty":-15.136473,"median":-2.154777,"eighty":-0.57191,"marketCap":6336008},{"date":"2024-01-26","current":-0.20413,"twenty":-15.076869,"median":-2.114779,"eighty":-0.557875,"marketCap":5935279},{"date":"2024-02-02","current":-0.231491,"twenty":-14.993423,"median":-2.043694,"eighty":-0.501381,"marketCap":6730827},{"date":"2024-02-09","current":-0.243931,"twenty":-14.972324,"median":-2.011125,"eighty":-0.494052,"marketCap":7092547},{"date":"2024-02-16","current":-0.247997,"twenty":-14.950896,"median":-2.00305,"eighty":-0.485846,"marketCap":7210756},{"date":"2024-02-23","current":-0.304914,"twenty":-14.932329,"median":-1.984457,"eighty":-0.475253,"marketCap":8865684},{"date":"2024-03-01","current":-0.278488,"twenty":-14.901037,"median":-1.948914,"eighty":-0.459011,"marketCap":8097324},{"date":"2024-03-08","current":-0.390435,"twenty":-14.877195,"median":-1.940029,"eighty":-0.451949,"marketCap":9456729},{"date":"2024-03-15","current":-0.486178,"twenty":-14.817591,"median":-1.937067,"eighty":-0.451949,"marketCap":11775725},{"date":"2024-03-22","current":-0.462661,"twenty":-14.763947,"median":-1.932624,"eighty":-0.451949,"marketCap":11206115},{"date":"2024-03-28","current":-0.451577,"twenty":-14.728184,"median":-1.922257,"eighty":-0.451601,"marketCap":10937645},{"date":"2024-04-05","current":-0.457442,"twenty":-14.66262,"median":-1.853108,"eighty":-0.451601,"marketCap":11079693},{"date":"2024-04-12","current":-0.445712,"twenty":-14.588115,"median":-1.655689,"eighty":-0.451601,"marketCap":10795598},{"date":"2024-04-19","current":-0.410525,"twenty":-14.442085,"median":-1.587565,"eighty":-0.446181,"marketCap":9943314},{"date":"2024-04-26","current":-0.38648,"twenty":-14.248371,"median":-1.495937,"eighty":-0.441357,"marketCap":9360920},{"date":"2024-05-03","current":-0.431168,"twenty":-14.162243,"median":-1.463167,"eighty":-0.433831,"marketCap":10443321},{"date":"2024-05-10","current":-0.475036,"twenty":-14.102788,"median":-1.412815,"eighty":-0.432294,"marketCap":11505835},{"date":"2024-05-17","current":-0.639125,"twenty":-14.048698,"median":-1.380234,"eighty":-0.43552,"marketCap":12358119},{"date":"2024-05-24","current":-0.61697,"twenty":-13.980153,"median":-1.37476,"eighty":-0.437826,"marketCap":11929739},{"date":"2024-05-31","current":-0.779486,"twenty":-13.902667,"median":-1.323959,"eighty":-0.438113,"marketCap":15072137},{"date":"2024-06-07","current":-0.838241,"twenty":-13.834122,"median":-1.249912,"eighty":-0.43968,"marketCap":16208235},{"date":"2024-06-14","current":-0.845669,"twenty":-13.79836,"median":-1.232357,"eighty":-0.441357,"marketCap":16351847},{"date":"2024-06-21","current":-0.683888,"twenty":-13.774518,"median":-1.222913,"eighty":-0.441357,"marketCap":13223668},{"date":"2024-06-28","current":-0.714039,"twenty":-13.732795,"median":-1.214369,"eighty":-0.441357,"marketCap":13806661},{"date":"2024-07-05","current":-0.711465,"twenty":-13.589745,"median":-1.208445,"eighty":-0.441357,"marketCap":13756880},{"date":"2024-07-12","current":-0.838315,"twenty":-13.559943,"median":-1.202522,"eighty":-0.441357,"marketCap":16209657},{"date":"2024-07-15","current":-0.815592,"twenty":-13.556963,"median":-1.19956,"eighty":-0.442228,"marketCap":15770290},{"date":"2024-08-02","current":-0.856699,"twenty":-13.553983,"median":-1.199412,"eighty":-0.443099,"marketCap":16565132},{"date":"2024-08-09","current":-0.742791,"twenty":-13.533121,"median":-1.196598,"eighty":-0.446181,"marketCap":14362609},{"date":"2024-08-16","current":-0.794193,"twenty":-13.061245,"median":-1.187712,"eighty":-0.44712,"marketCap":15356517},{"date":"2024-08-23","current":-1.15671,"twenty":-12.142357,"median":-1.18475,"eighty":-0.449067,"marketCap":17347177},{"date":"2024-08-30","current":-1.876643,"twenty":-11.785515,"median":-1.187712,"eighty":-0.451507,"marketCap":28144012},{"date":"2024-09-06","current":-2.192608,"twenty":-11.766095,"median":-1.196569,"eighty":-0.451589,"marketCap":32882545},{"date":"2024-09-13","current":-1.914942,"twenty":-11.59617,"median":-1.199263,"eighty":-0.451699,"marketCap":28718380},{"date":"2024-09-20","current":-1.608551,"twenty":-11.219907,"median":-1.206964,"eighty":-0.451949,"marketCap":24123439},{"date":"2024-09-27","current":-1.503229,"twenty":-11.156792,"median":-1.208445,"eighty":-0.451949,"marketCap":22543928},{"date":"2024-10-04","current":-1.445781,"twenty":-10.999005,"median":-1.224565,"eighty":-0.452015,"marketCap":21682376},{"date":"2024-10-11","current":-1.148965,"twenty":-10.88734,"median":-1.232357,"eighty":-0.452921,"marketCap":17231028},{"date":"2024-10-18","current":-1.225563,"twenty":-10.785385,"median":-1.22589,"eighty":-0.45548,"marketCap":18379763},{"date":"2024-10-25","current":-1.378758,"twenty":-10.736835,"median":-1.235137,"eighty":-0.455755,"marketCap":20677233},{"date":"2024-10-31","current":-1.359609,"twenty":-10.620315,"median":-1.249912,"eighty":-0.456855,"marketCap":20390049},{"date":"2024-11-08","current":-1.417057,"twenty":-10.45039,"median":-1.266908,"eighty":-0.457442,"marketCap":21251601},{"date":"2024-11-15","current":-1.665999,"twenty":-10.292602,"median":-1.32131,"eighty":-0.459011,"marketCap":24984990},{"date":"2024-11-22","current":-2.095324,"twenty":-10.231915,"median":-1.363998,"eighty":-0.459011,"marketCap":30170577},{"date":"2024-11-29","current":-2.383432,"twenty":-9.921194,"median":-1.369183,"eighty":-0.461931,"marketCap":34319032},{"date":"2024-12-06","current":-2.160803,"twenty":-9.756124,"median":-1.373971,"eighty":-0.462708,"marketCap":31113408},{"date":"2024-12-13","current":-2.213186,"twenty":-9.705147,"median":-1.378758,"eighty":-0.463189,"marketCap":31867672},{"date":"2024-12-20","current":-2.121516,"twenty":-9.600764,"median":-1.380234,"eighty":-0.463306,"marketCap":30547709},{"date":"2024-12-27","current":-2.60606,"twenty":-9.569207,"median":-1.380234,"eighty":-0.463517,"marketCap":37524655},{"date":"2025-01-03","current":-2.789401,"twenty":-9.530367,"median":-1.398005,"eighty":-0.464624,"marketCap":40164581},{"date":"2025-01-10","current":-2.907263,"twenty":-9.476962,"median":-1.417057,"eighty":-0.466165,"marketCap":41861676},{"date":"2025-01-17","current":-2.553677,"twenty":-9.428412,"median":-1.440994,"eighty":-0.466978,"marketCap":36770391},{"date":"2025-01-24","current":-2.776305,"twenty":-9.273052,"median":-1.445781,"eighty":-0.46876,"marketCap":39976015},{"date":"2025-01-31","current":-2.671539,"twenty":-9.151677,"median":-1.455356,"eighty":-0.469171,"marketCap":38467486},{"date":"2025-02-07","current":-2.737018,"twenty":-9.018164,"median":-1.469718,"eighty":-0.473135,"marketCap":39410316},{"date":"2025-02-14","current":-2.592964,"twenty":-8.836102,"median":-1.480938,"eighty":-0.473135,"marketCap":37336089},{"date":"2025-02-21","current":-2.317953,"twenty":-8.836102,"median":-1.503229,"eighty":-0.473248,"marketCap":33376201},{"date":"2025-02-28","current":-2.121516,"twenty":-8.758422,"median":-1.503229,"eighty":-0.474684,"marketCap":30547709},{"date":"2025-03-07","current":-2.001275,"twenty":-8.680742,"median":-1.510936,"eighty":-0.476339,"marketCap":27907784},{"date":"2025-03-14","current":-1.879576,"twenty":-8.578787,"median":-1.515197,"eighty":-0.47949,"marketCap":26210689},{"date":"2025-03-21","current":-1.825488,"twenty":-8.491203,"median":-1.551103,"eighty":-0.480196,"marketCap":25456424},{"date":"2025-03-28","current":-1.487434,"twenty":-8.453115,"median":-1.55589,"eighty":-0.482636,"marketCap":20742272},{"date":"2025-04-04","current":-1.446868,"twenty":-8.42079,"median":-1.528001,"eighty":-0.483668,"marketCap":20176573},{"date":"2025-04-11","current":-1.27108,"twenty":-8.411844,"median":-1.519998,"eighty":-0.485697,"marketCap":17725214},{"date":"2025-04-17","current":-1.568567,"twenty":-8.391098,"median":-1.525203,"eighty":-0.486826,"marketCap":21873668},{"date":"2025-04-25","current":-1.744355,"twenty":-8.375981,"median":-1.528001,"eighty":-0.487258,"marketCap":24325028},{"date":"2025-05-02","current":-1.852532,"twenty":-8.369248,"median":-1.55589,"eighty":-0.487258,"marketCap":25833557},{"date":"2025-05-09","current":-1.663222,"twenty":-8.278077,"median":-1.568567,"eighty":-0.49069,"marketCap":23193631},{"date":"2025-05-16","current":-1.815301,"twenty":-8.203608,"median":-1.575039,"eighty":-0.493783,"marketCap":24325028},{"date":"2025-05-23","current":-1.913805,"twenty":-8.187149,"median":-1.582089,"eighty":-0.49432,"marketCap":25644990},{"date":"2025-05-30","current":-1.948554,"twenty":-8.178517,"median":-1.596287,"eighty":-0.495732,"marketCap":26110621},{"date":"2025-06-06","current":-1.887773,"twenty":-8.150735,"median":-1.606944,"eighty":-0.498765,"marketCap":25296161},{"date":"2025-06-13","current":-1.74476,"twenty":-8.067637,"median":-1.629032,"eighty":-0.500634,"marketCap":23379785},{"date":"2025-06-20","current":-1.74476,"twenty":-7.9813,"median":-1.636178,"eighty":-0.501381,"marketCap":23379785},{"date":"2025-06-27","current":-1.707005,"twenty":-7.916079,"median":-1.655456,"eighty":-0.501977,"marketCap":22873862},{"date":"2025-07-03","current":-1.658952,"twenty":-7.780139,"median":-1.658952,"eighty":-0.504359,"marketCap":22229960},{"date":"2025-07-11","current":-1.658952,"twenty":-7.697713,"median":-1.658952,"eighty":-0.52119,"marketCap":22229960},{"date":"2025-07-18","current":-1.616048,"twenty":-7.199911,"median":-1.658952,"eighty":-0.533159,"marketCap":21655047},{"date":"2025-07-25","current":-1.558843,"twenty":-6.568553,"median":-1.653661,"eighty":-0.554344,"marketCap":20888497},{"date":"2025-08-01","current":-1.53024,"twenty":-6.54427,"median":-1.644651,"eighty":-0.557875,"marketCap":20505222},{"date":"2025-08-08","current":-1.387229,"twenty":-6.337865,"median":-1.636178,"eighty":-0.557875,"marketCap":18588865},{"date":"2025-08-15","current":-1.283257,"twenty":-6.228591,"median":-1.629691,"eighty":-0.564937,"marketCap":17195640},{"date":"2025-08-22","current":-1.54853,"twenty":-6.107176,"median":-1.627269,"eighty":-0.567559,"marketCap":18312912},{"date":"2025-08-29","current":-1.491663,"twenty":-6.088434,"median":-1.624963,"eighty":-0.571556,"marketCap":17640403},{"date":"2025-09-05","current":-1.334185,"twenty":-6.025722,"median":-1.616048,"eighty":-0.57191,"marketCap":15778073},{"date":"2025-09-12","current":-1.334185,"twenty":-5.961478,"median":-1.606272,"eighty":-0.574823,"marketCap":15778073},{"date":"2025-09-19","current":-1.150461,"twenty":-5.949191,"median":-1.602755,"eighty":-0.575548,"marketCap":13605355},{"date":"2025-09-26","current":-1.093594,"twenty":-5.89102,"median":-1.587565,"eighty":-0.575553,"marketCap":12932847},{"date":"2025-10-03","current":-1.181082,"twenty":-5.808495,"median":-1.579827,"eighty":-0.578359,"marketCap":13967475},{"date":"2025-10-10","current":-1.474165,"twenty":-5.742931,"median":-1.573144,"eighty":-0.579452,"marketCap":17433478},{"date":"2025-10-17","current":-1.434796,"twenty":-5.682224,"median":-1.568567,"eighty":-0.581983,"marketCap":16967895},{"date":"2025-10-24","current":-1.272944,"twenty":-5.670082,"median":-1.560677,"eighty":-0.583355,"marketCap":15053834},{"date":"2025-10-31","current":-1.303565,"twenty":-5.611803,"median":-1.558843,"eighty":-0.586744,"marketCap":15415954},{"date":"2025-11-07","current":-1.128589,"twenty":-5.538954,"median":-1.557278,"eighty":-0.590741,"marketCap":13346698},{"date":"2025-11-14","current":-1.115466,"twenty":-5.51467,"median":-1.546536,"eighty":-0.59154,"marketCap":13191504},{"date":"2025-11-21","current":-1.062974,"twenty":-5.44425,"median":-1.531032,"eighty":-0.594738,"marketCap":12570727},{"date":"2025-11-28","current":-1.599048,"twenty":-5.419967,"median":-1.53024,"eighty":-0.595537,"marketCap":16126403},{"date":"2025-12-05","current":-1.5075,"twenty":-5.40054,"median":-1.530636,"eighty":-0.595537,"marketCap":15203136},{"date":"2025-12-12","current":-1.440364,"twenty":-5.354403,"median":-1.53024,"eighty":-0.596244,"marketCap":14526073},{"date":"2025-12-19","current":-1.171822,"twenty":-5.30098,"median":-1.526236,"eighty":-0.597136,"marketCap":11817822},{"date":"2025-12-26","current":-1.147409,"twenty":-5.276697,"median":-1.522344,"eighty":-0.597644,"marketCap":11571618},{"date":"2026-01-02","current":-1.007034,"twenty":-5.269412,"median":-1.518648,"eighty":-0.598296,"marketCap":10155941},{"date":"2026-01-09","current":-1.098583,"twenty":-5.228131,"median":-1.513603,"eighty":-0.599676,"marketCap":11079208},{"date":"2026-01-16","current":-1.037551,"twenty":-5.060579,"median":-1.51187,"eighty":-0.600245,"marketCap":10463697},{"date":"2026-01-23","current":-1.043654,"twenty":-5.050865,"median":-1.50833,"eighty":-0.600245,"marketCap":10525248},{"date":"2026-01-30","current":-0.958208,"twenty":-5.014441,"median":-1.507043,"eighty":-0.600245,"marketCap":9663532},{"date":"2026-02-06","current":-0.88497,"twenty":-4.905167,"median":-1.503229,"eighty":-0.602394,"marketCap":8924918},{"date":"2026-02-13","current":-0.903279,"twenty":-4.853179,"median":-1.503229,"eighty":-0.603531,"marketCap":9109571},{"date":"2026-02-20","current":-1.000931,"twenty":-4.83649,"median":-1.487434,"eighty":-0.603727,"marketCap":10094390},{"date":"2026-02-27","current":-0.946002,"twenty":-4.764326,"median":-1.483497,"eighty":-0.606601,"marketCap":9540429},{"date":"2026-03-06","current":-1.116893,"twenty":-4.698762,"median":-1.47854,"eighty":-0.607484,"marketCap":11263862},{"date":"2026-03-13","current":-1.135202,"twenty":-4.644385,"median":-1.47476,"eighty":-0.607528,"marketCap":11448515},{"date":"2026-03-20","current":-1.320664,"twenty":-4.602751,"median":-1.474039,"eighty":-0.610975,"marketCap":11879373},{"date":"2026-03-27","current":-1.239357,"twenty":-4.436409,"median":-1.464049,"eighty":-0.610975,"marketCap":11148012},{"date":"2026-04-02","current":-1.272775,"twenty":-4.376087,"median":-1.449094,"eighty":-0.610975,"marketCap":11448615},{"date":"2026-04-10","current":-1.336814,"twenty":-4.068993,"median":-1.441385,"eighty":-0.610975,"marketCap":12024646},{"date":"2026-04-17","current":-1.336814,"twenty":-3.836845,"median":-1.428878,"eighty":-0.610975,"marketCap":12024646},{"date":"2026-04-24","current":-1.29679,"twenty":-3.62846,"median":-1.412269,"eighty":-0.610975,"marketCap":11664626},{"date":"2026-05-01","current":-1.176717,"twenty":-3.456633,"median":-1.387701,"eighty":-0.610975,"marketCap":10584568},{"date":"2026-05-08","current":-1.392849,"twenty":-3.112981,"median":-1.383659,"eighty":-0.610975,"marketCap":12528673},{"date":"2026-05-15","current":-1.360829,"twenty":-2.937957,"median":-1.380234,"eighty":-0.610975,"marketCap":12240657},{"date":"2026-05-22","current":-1.7602,"twenty":-2.886316,"median":-1.380234,"eighty":-0.610975,"marketCap":13104686},{"date":"2026-05-29","current":-2.001985,"twenty":-2.842446,"median":-1.380234,"eighty":-0.610838,"marketCap":14904780},{"date":"2026-06-05","current":-1.740857,"twenty":-2.789401,"median":-1.380234,"eighty":-0.610975,"marketCap":12960678},{"date":"2026-06-12","current":-1.721514,"twenty":-2.77491,"median":-1.380234,"eighty":-0.610975,"marketCap":12816671},{"date":"2026-06-18","current":-1.45555,"twenty":-2.737018,"median":-1.380234,"eighty":-0.610975,"marketCap":10836567},{"date":"2026-06-26","current":-1.508743,"twenty":-2.715019,"median":-1.380234,"eighty":-0.610838,"marketCap":11232588},{"date":"2026-07-02","current":-1.644142,"twenty":-2.671539,"median":-1.380234,"eighty":-0.610838,"marketCap":12240640},{"date":"2026-07-10","current":-1.769871,"twenty":-2.645347,"median":-1.380234,"eighty":-0.610838,"marketCap":13176689},{"date":"2026-07-17","current":-1.470057,"twenty":-2.60606,"median":-1.380234,"eighty":-0.610838,"marketCap":10944573},{"date":"2026-07-24","current":-1.354,"twenty":-2.592964,"median":-1.380234,"eighty":-0.610838,"marketCap":10080527},{"date":"2026-07-31","current":-1.479728,"twenty":-2.556296,"median":-1.379007,"eighty":-0.610838,"marketCap":11016576},{"date":"2026-08-07","current":-1.740857,"twenty":-2.513906,"median":-1.379007,"eighty":-0.610838,"marketCap":12960678},{"date":"2026-08-14","current":-1.837571,"twenty":-2.48578,"median":-1.379007,"eighty":-0.610838,"marketCap":13680716},{"date":"2026-08-21","current":-1.985755,"twenty":-2.434898,"median":-1.379007,"eighty":-0.610838,"marketCap":14998406},{"date":"2026-08-28","current":-2.609301,"twenty":-2.393239,"median":-1.379007,"eighty":-0.610838,"marketCap":19708051},{"date":"2026-08-31","current":-2.599708,"twenty":-2.393239,"median":-1.379007,"eighty":-0.610838,"marketCap":19635594}],"updateTime":1788277205121},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CMMB\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2635748474","title":"Chemomab Therapeutics Ltd reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2635748474","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635748474?lang=en_us&edition=fundamental","pubTime":"2026-05-14 21:31","pubTimestamp":1778765498,"startTime":"0","endTime":"0","summary":"Chemomab Therapeutics Ltd reports results for the quarter ended March 31 - Earnings SummaryChemomab Therapeutics Ltd CMMB.OQ reported a quarterly adjusted loss of 24 cents per share for the quarter en","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nL8N41R1ID:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMMB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635712386","title":"Chemomab Q1 FY26 net loss narrows to $1.8 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635712386","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635712386?lang=en_us&edition=fundamental","pubTime":"2026-05-14 20:01","pubTimestamp":1778760115,"startTime":"0","endTime":"0","summary":"Chemomab Therapeutics posted a Q1 net loss of $1.8 million, narrowing from a $3.3 million loss a year earlier.R&D expense fell to $0.9 million from $2.5 million, due to continued winding down of activities related to the Phase 2 SPRING trial; G&A expense edged down to $0.9 million from $1.0 million.Cash, cash equivalents and short-term bank deposits declined to $8.0 million as of March 31, 2026, from $10.4 million at end-2025, with runway expected to fund operations through end of Q1 2027.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Chemomab Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exc","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nNDL9PzSZg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CMMB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635363712","title":"Press Release: Chemomab Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2635363712","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635363712?lang=en_us&edition=fundamental","pubTime":"2026-05-14 20:00","pubTimestamp":1778760000,"startTime":"0","endTime":"0","summary":"--New Clinical and Translational Data Presented at Major Medical Meetings Further Confirms the Disease-Modifying Potential of Nebokitug in Primary Sclerosing Cholangitis and Suggests Possible Additional Benefit in PSC Patients with Co-Existing IBD--. --Company Continues to Advance Multiple Partnering Options for Nebokitug--. TEL AVIV, Israel, May 14, 2026  -- Chemomab Therapeutics Ltd. , , a clinical-stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced financial and operating results for the first quarter ended March 31, 2026, and provided a corporate update.-- On May 30, 2026, Chemomab will present data from three abstracts at EASL. -- In one EASL 2026 study1, Olink-generated analyses of circulating. proteins in patient samples from the SPRING trial were used to. generate an AI/machine learning model to identify patients who. showed a combined improvement in all three key fibrosis-related. measures: ELF sc","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","R","BK4022","BK4023","CMMB","PSC","BK4007","BK4116","BK4139","BK4539","BK6053","CD","DM0.SI","IBD","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634855287","title":"Chemomab Therapeutics Ltd  expected to post a loss of 15 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2634855287","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634855287?lang=en_us&edition=fundamental","pubTime":"2026-05-11 21:45","pubTimestamp":1778507106,"startTime":"0","endTime":"0","summary":"Chemomab Therapeutics Ltd  expected to post a loss of15cents a share - Earnings Preview Chemomab Therapeutics Ltd CMMB.OQ CMMB.O is expected to  report resultson May 13 (estimated) for the period endi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nL8N41O1HJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CMMB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633139163","title":"Chemomab Therapeutics holds annual shareholders meeting, re-elects directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2633139163","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633139163?lang=en_us&edition=fundamental","pubTime":"2026-05-07 06:02","pubTimestamp":1778104941,"startTime":"0","endTime":"0","summary":"Chemomab Therapeutics held its annual general shareholders meeting on May 5, 2026, following an adjournment from April 28, 2026.Shareholders backed re-appointment of Somekh Chaikin, a KPMG member firm, as independent registered public accounting firm for fiscal 2026.Authorization was granted to increase authorized share capital, including an amendment to articles of association to reflect the change; execution of the increase was not confirmed.Class II director appointments for Neil Cohen and Claude Nicaise were approved; seating of the directors was not confirmed.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Chemomab Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gath","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nNDLbLPxGC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CMMB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626100821","title":"Chemomab Therapeutics director Neil Cohen files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2626100821","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626100821?lang=en_us&edition=fundamental","pubTime":"2026-04-11 04:14","pubTimestamp":1775852044,"startTime":"0","endTime":"0","summary":"Chemomab Therapeutics director Neil Cohen filed an initial beneficial ownership statement reporting 35,304 American depositary shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Chemomab Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 10, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nNDLh9ZL0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CMMB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626110743","title":"Chemomab Therapeutics files Form 3 as director Nissim Darvish reports holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2626110743","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626110743?lang=en_us&edition=fundamental","pubTime":"2026-04-11 04:13","pubTimestamp":1775851981,"startTime":"0","endTime":"0","summary":"Chemomab Therapeutics director Nissim Darvish reported direct ownership of 300 American Depositary Shares in an initial SEC filing dated March 18, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Chemomab Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 10, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nNDL7l8qsj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CMMB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626110734","title":"Chemomab files Form 3 for CFO Fatal Sigal’s initial beneficial ownership stake","url":"https://stock-news.laohu8.com/highlight/detail?id=2626110734","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626110734?lang=en_us&edition=fundamental","pubTime":"2026-04-11 04:10","pubTimestamp":1775851830,"startTime":"0","endTime":"0","summary":"Chemomab Therapeutics CFO Sigal Fattal filed an initial Form 3 reporting 37,450 ADS held directly.Fattal also disclosed stock options covering 41,965 ADS with exercise prices of USD 39.31, USD 8.44, USD 6.8.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Chemomab Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 10, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nNDL8qSt4l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CMMB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626104201","title":"Chemomab files Form 3 for Chief Development Officer John Lawler","url":"https://stock-news.laohu8.com/highlight/detail?id=2626104201","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626104201?lang=en_us&edition=fundamental","pubTime":"2026-04-11 04:05","pubTimestamp":1775851518,"startTime":"0","endTime":"0","summary":"Chemomab Therapeutics Chief Development Officer John Lawler filed an initial SEC Form 3 reporting 30,648 American depositary shares held directly.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Chemomab Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 10, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nNDLQSxHV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMMB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624537418","title":"Chemomab files initial beneficial ownership statement for director Claude Nicaise","url":"https://stock-news.laohu8.com/highlight/detail?id=2624537418","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624537418?lang=en_us&edition=fundamental","pubTime":"2026-04-01 04:12","pubTimestamp":1774987953,"startTime":"0","endTime":"0","summary":"Chemomab Therapeutics director Claude Nicaise filed an initial beneficial ownership statement dated March 18, 2026.Filing disclosed stock options covering about 18,000 American Depositary Shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Chemomab Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 31, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDL8WRF9x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CMMB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624957537","title":"Chemomab files Form 3 for director Jill Quigley’s beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2624957537","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624957537?lang=en_us&edition=fundamental","pubTime":"2026-04-01 04:06","pubTimestamp":1774987562,"startTime":"0","endTime":"0","summary":"Chemomab Therapeutics director Jill Quigley filed an initial beneficial ownership statement dated March 18, 2026, reporting stock options covering about 11,616 ADS.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Chemomab Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 31, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDL702FqP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CMMB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620188731","title":"Maxim Group Remains a Buy on Chemomab Therapeutics (CMMB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2620188731","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620188731?lang=en_us&edition=fundamental","pubTime":"2026-03-20 21:35","pubTimestamp":1774013731,"startTime":"0","endTime":"0","summary":"In a report released today, Michael Okunewitch from Maxim Group reiterated a Buy rating on Chemomab Therapeutics, with a price target of $5.00. Oku...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/maxim-group-remains-a-buy-on-chemomab-therapeutics-cmmb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/maxim-group-remains-a-buy-on-chemomab-therapeutics-cmmb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CMMB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620247714","title":"Chemomab FY 2025 net loss fell 35.5% to USD 9 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2620247714","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620247714?lang=en_us&edition=fundamental","pubTime":"2026-03-19 20:04","pubTimestamp":1773921850,"startTime":"0","endTime":"0","summary":"Chemomab published a press release reporting full-year and fourth-quarter 2025 financial results and a corporate update.Cash, cash equivalents and short-term bank deposits were USD 10.4 million at Dec. 31, 2025, down 27%.R&D expense fell 55% to USD 5.83 million, reflecting lower clinical costs after completion of the nebokitug Phase 2 PSC trial.Net loss narrowed 35% to USD 9 million.Adi Mor said the company completed an FDA End-of-Phase 2 meeting and aligned on a single pivotal Phase 3 trial design in primary sclerosing cholangitis, while maintaining a cash runway expected to last through the end of Q1 2027.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nNDL8N8Q8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","SG9999014013.SGD","SG9999014021.USD","LU0314104364.USD","CMMB","IE00BKPKM429.USD","LU2210150020.SGD","IE00BN0W2V16.EUR","SG9999014039.USD","SG9999014005.SGD","BK4139","IE00BGHQF748.EUR","BK4112","LU2095319765.USD","BK4585","IE00BN0W2W23.USD","IE00B64PRP62.GBP","NDAQ","BK4588","IE00B3QW5Z07.USD","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620247077","title":"Chemomab Therapeutics: Evaluating Additional Therapeutic Indications Where Nebokitug Has Generated Robust Preclinical Efficacy Signals","url":"https://stock-news.laohu8.com/highlight/detail?id=2620247077","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620247077?lang=en_us&edition=fundamental","pubTime":"2026-03-19 20:00","pubTimestamp":1773921605,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nTUA9T27GH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CMMB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620247138","title":"Chemomab Therapeutics Q4 Operating Expenses USD 1.974 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2620247138","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620247138?lang=en_us&edition=fundamental","pubTime":"2026-03-19 20:00","pubTimestamp":1773921601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nPLXF56915:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CMMB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620252247","title":"Press Release: Chemomab Therapeutics Announces Year End and Fourth Quarter 2025 Financial Results and Provides a Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2620252247","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620252247?lang=en_us&edition=fundamental","pubTime":"2026-03-19 20:00","pubTimestamp":1773921600,"startTime":"0","endTime":"0","summary":"--Completed Successful FDA End-of-Phase 2 Meeting Following Positive Nebokitug Phase 2 SPRING Trial Results in Primary Sclerosing Cholangitis --. --Achieved Alignment with FDA on Clear and Efficient Pathway to Potential Approval for the Treatment of PSC--. --Multiple Scientific Presentations and Publications Raised Awareness of Nebokitug's Potential to Become the First Disease-Modifying Treatment for PSC and Its Relevance to Other Fibro-Inflammatory Conditions--. Dr. Mor added, \"Our discussions with potential strategic partners continue to advance as we progress activities required for the timely initiation of the Phase 3 trial in PSC. In parallel, we are evaluating additional therapeutic indications where nebokitug has generated robust preclinical efficacy signals, providing a strong mechanistic and translational rationale for future clinical development.\". trial assessing nebokitug for the treatment of PSC wa","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BFXG1179.USD","LU1363072403.SGD","LU2237443622.USD","LU2237443382.USD","IE00BHPRN162.USD","BK4006","DM0.SI","LU2746668974.SGD","R","CMC","BK4539","BK4022","BK6053","BK4181","BK4232","LU2746668461.USD","BK4007","BK4139","LENZ","IE00B1BXHZ80.USD","LU2237443465.HKD","LU0971096721.USD","CMMB","LU0170899867.USD","LU2237443895.HKD","BK4218","PSC","LU0149725797.USD","LU0267386448.USD","LU2237443978.SGD","LU0882574139.USD","INN","LABU","LU2237443549.SGD","IE00BKVL7J92.USD","BK4588","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":36,"code":"91000000","status":"200"}]}}